Phase 1b Dose-finding Study of Venetoclax With Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma. Issue 6 (12th June 2022)

Record Type:: Journal Article
Title:: Phase 1b Dose-finding Study of Venetoclax With Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma. Issue 6 (12th June 2022)
Main Title:: Phase 1b Dose-finding Study of Venetoclax With Ibrutinib and Rituximab in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Authors:: Petrillo, Alessandra
Ip, Andrew
Della Pia, Alexandra
Gill, Sarvainder
Zenreich, Joshua
Gutierrez, Martin
McNeill, Ann
Feldman, Tatyana
Leslie, Lori A.
Goy, Andre
Abstract:
Is Part Of:: HemaSphere. Volume 6:Issue 6(2022)
Journal:: HemaSphere
Issue:: Volume 6:Issue 6(2022)
Issue Display:: Volume 6, Issue 6 (2022)
Year:: 2022
Volume:: 6
Issue:: 6
Issue Sort Value:: 2022-0006-0006-0000
Page Start:: e719
Page End:
Publication Date:: 2022-06-12
Subjects:: Hematology -- Periodicals
616.15005
Journal URLs:: https://journals.lww.com/hemasphere/pages/default.aspx ↗
http://journals.lww.com/pages/default.aspx ↗
DOI:: 10.1097/HS9.0000000000000719 ↗
Languages:: English
ISSNs:: 2572-9241
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 21597.xml